Send Message
Wuhan Desheng Biochemical Technology Co., Ltd
Wuhan Desheng Biochemical Technology Co., Ltd
news
Home / news /

Company News About CMEF exhibition hits: heat surges, crowds surge, Hubei Xindesheng 8.2ZA31 grand event continues to explode

CMEF exhibition hits: heat surges, crowds surge, Hubei Xindesheng 8.2ZA31 grand event continues to explode

2025-04-09
CMEF exhibition hits: heat surges, crowds surge, Hubei Xindesheng 8.2ZA31 grand event continues to explode

On April 8, 2025, the Shanghai National Convention and Exhibition Center welcomed the grand opening of the 91st China International Medical Equipment Fair (CMEF). As a benchmark for the medical industry both domestically and internationally, this exhibition, with the theme of "Innovative Technology, Leading the Future with Intelligence", has attracted nearly 5000 companies from more than 30 countries and regions to participate. The exhibition area covers 320000 square meters and is expected to attract over 200000 professional visitors. In this industry feast focusing on cutting-edge technologies such as AI medicine, gene sequencing, surgical robots, etc., Hubei Xindesheng Material Technology Co., Ltd. (booth number: 8.2ZA31) has become one of the focuses of the in vitro diagnostics (IVD) exhibition area with its advantages in the full range of IVD reagent raw materials.


1, Exhibition Overview: Empowered by Technology, Leading the Future with Intelligence


This year's CMEF focuses on "AI+Robotics" and has built a full industry chain ecosystem covering 22 themed exhibition areas such as medical imaging, in vitro diagnostics, and medical electronics. Cutting edge technologies such as AI medicine, 3D bioprinting, and digital therapy, along with tens of thousands of innovative products, have been showcased, showcasing new achievements in medical technology. In addition, nearly a hundred forums and academic conferences were held simultaneously, focusing on hot topics such as policies and regulations, market development, and medical engineering transformation. Nearly a thousand industry experts gathered to explore the future trends of the medical industry.


2, New Desheng showcases its full range of products at CMEF


In the in vitro diagnostic exhibition area, Hubei Xindesheng has set up booth 8.2ZA31 to comprehensively showcase its technical strength and product matrix in the field of IVD reagent raw materials. As a domestic IVD reagent raw material advantage R&D and production manufacturer, Xindesheng showcased its full range of IVD core raw materials, including:


(1) Biological buffering agents: HEPES, MOPS, Tris, CAPS, Tris HCL, BICINE, TAPS, MOPSO, PIPES, etc;


(2) Luminescent reagents: 7 types including luminol, isoluminol, and acridine ester;


(3) Enzyme preparations: adenosine deaminase, pyruvate kinase, cholesterol oxidase, glycerol kinase, uricase-2, etc;


(4) Chromogenic substrates: TOOS, MAOS, DAOS, TOPS, ADOS, ADPS, ALPS, etc


Covering mainstream technology platforms such as chemiluminescence and enzyme-linked immunosorbent assay. During the exhibition, it attracted customers from multiple regions abroad to stop and exchange ideas. With the promotion of the policy of volume based centralized procurement, the profit margin of biochemical diagnostic reagents has narrowed, while immune diagnosis (especially chemiluminescence) and molecular diagnosis have become growth engines. As one of the few domestic enterprises with full supply chain capabilities, Xindesheng has demonstrated strong competitiveness in the import substitution process of luminescent reagents and chromogenic substrates.


3, Deeply cultivating raw materials for 20 years, empowering downstream manufacturers to diagnose the future


As the crowd of CMEF gradually dispersed, what Hubei Xindesheng left behind at booth 8.2ZA31 was not only a highlight moment for product display, but also a firm step towards domestic substitution of IVD raw materials. From accurate regulation of biological buffering agents, to breakthroughs in sensitivity of luminescent reagents, and to the domestic and international market layout of enzyme preparations, Xindesheng has proven with 20 years of technological accumulation that raw material quality is the core driving force for the upgrading of diagnostic technology and an important guarantee for enterprise development.


The New Desheng booth will continue to be open until April 11th. On August 23rd, ZA31, we sincerely invite you to explore the new future of IVD raw materials together!